Skip To Main Content
Barbara C. Gärtner on Muck Rack

Barbara C. Gärtner

Munich
As seen in: Color Research & Application, Nature, British Journal of Sports Medicine, MDPI, Taylor & Francis Online, JAMA (The Journal of the American Medical Association), The Lancet, AD Magazine Spain, Future Medicine, AD Magazin
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barbara C.

Contact Barbara C., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

STIKO-Empfehlung: MF59-adjuvantierter Influenza-Impfstoff für Menschen ≥ 60 Jahre

|
By Martina Prelog, Barbara C. Gärtner, Universitätsklinikum des Saarlandes
| thieme-connect.de
Die Ständige Impfkommission (STIKO) hat im Oktober 2024 ihre Empfehlung zur saisonalen Influenza-Impfung für Personen ab 60 Jahren angepasst. Aufgrund neuer Studiendaten wird der MF59-adjuvantierte Influenza-Impfstoff nun neben dem Hochdosis-Impfstoff gleichwertig empfohlen: Es zeigte sich eine Überlegenheit des MF59-adjuvantierten Impfstoffs hinsichtlich der Effektivität im Vergleich zu nicht-adjuvantierten Standardimpfstoffen bei älteren Erwachsenen.
Open in Who Shared Issue with article?

SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4/5 COVID-19-vaccination in previously infected and non-infected individuals - Nature Communications

|
By Saskia Bronder, Sophie Schneitler, Sören L. Becker, Barbara C. Gärtner, Leonardo Martinez, Marek Widera, Tina Schmidt
| Nature Verified
Abstract Knowledge is limited as to how prior SARS-CoV-2 infection influences cellular and humoral immunity after booster-vaccination with bivalent BA.4/5-adapted mRNA-vaccines, and whether vaccine-induced immunity may indicate subsequent infection. In this observational study, individuals with prior infection (n = 64) showed higher vaccine-induced anti-spike IgG-antibodies and neutralizing titers, but the relative increase was significantly higher in non-infected individuals (n = 63).
Open in Who Shared Issue with article?

Dental aerosol-producing treatments: Comparison of contamination patterns of face shields and surgical masks

|
By Matthias Hannig, Barbara C. Gärtner, Stefan Rupf, Alexander Halfmann
| Taylor & Francis Online
Abstract During the COVID-19 pandemic, dental face shields were recommended to protect the eyes. This study aimed to examine to what extent face shield and mask contamination differ when a pre-procedural mouth rinsing with Chlorhexidine (CHX) is conducted before treatment. In this prospective, randomized study, three groups of subjects were formed (rinsing with 0.1% CHX, water, or no rinsing (control) before aerosol-producing treatments).
Open in Who Shared Issue with article?
See all 14 articles